Back to mobile site

Amicus Therapeutics, Inc. (FOLD) Tops Q3 EPS by 5c

November 1, 2011 4:42 PM EDT
Amicus Therapeutics, Inc. (NASDAQ: FOLD) reported Q3 EPS of ($0.28), $0.05 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $5.07 million.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings